Literature DB >> 27214734

Guidelines for therapy and optimal dosages of coagulation factors for treatment of bleeding and surgery in haemophilia.

K A Rickard1.   

Abstract

Entities:  

Year:  1995        PMID： 27214734     DOI： 10.1111/j.1365-2516.1995.tb00104.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  5 in total

Review 1.  Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia.

Authors:  S Björkman; E Berntorp
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  Cost-utility analysis of primary prophylaxis versus treatment on-demand for individuals with severe haemophilia.

Authors:  Alexander H Miners; Caroline A Sabin; Keith H Tolley; Christine A Lee
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

3.  Endovascular management of a mandibular arteriovenous malformation in a patient with severe hemophilia a.

Authors:  Goetz Benndorf; Doris M Kim; Horst Menneking; Martin Klein
Journal:  AJNR Am J Neuroradiol       Date:  2004-04       Impact factor: 3.825

4.  Management of Odontogenic Fascial Space Infection in Hemophilia Patients: A Proposed Protocol.

Authors:  Md Kalim Ansari; Ghulam Sarwar Hashmi; Syed Saeed Ahmed; Sajjad Abdur Rahman; Tabishur Rahman
Journal:  J Maxillofac Oral Surg       Date:  2018-05-09

5.  Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial).

Authors:  Nicola Curry; Canan Albayrak; Miguel Escobar; Pål Andre Holme; Susan Kearney; Robert Klamroth; Mudi Misgav; Claude Négrier; Allison Wheeler; Elena Santagostino; Midori Shima; Andrea Landorph; Sidsel Marie Tønder; Steven R Lentz
Journal:  Haemophilia       Date:  2019-02-28       Impact factor: 4.287
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.